S 3267 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
To amend title XVIII of the Social Security Act to provide for Medicare coverage of blood-based dementia screening tests.
Summary
This bill amends Medicare law to cover blood-based and other biomarker-based tests for early detection of Alzheimer's disease and related dementias, effective January 1, 2028. Eligible tests must be cleared, classified, or approved by the FDA and may include genomic sequencing blood tests, protein expression tests, whole genome sequencing, and other equivalent biomarker-based tests as determined by the Secretary of Health and Human Services. The bill also modifies Medicare payment provisions to include payment for these screening tests.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
43 cosponsors
- Sen. Armstrong, Alan [R-OK] (R-OK)
- Sen. Banks, Jim [R-IN] (R-IN)
- Sen. Bennet, Michael F. [D-CO] (D-CO)
- Sen. Blunt Rochester, Lisa [D-DE] (D-DE)
- Sen. Booker, Cory A. [D-NJ] (D-NJ)
- Sen. Britt, Katie Boyd [R-AL] (R-AL)
- Sen. Cantwell, Maria [D-WA] (D-WA)
- Sen. Capito, Shelley Moore [R-WV] (R-WV)
- Sen. Coons, Christopher A. [D-DE] (D-DE)
- Sen. Cortez Masto, Catherine [D-NV] (D-NV)
- Sen. Cramer, Kevin [R-ND] (R-ND)
- Sen. Daines, Steve [R-MT] (R-MT)
- Sen. Duckworth, Tammy [D-IL] (D-IL)
- Sen. Fischer, Deb [R-NE] (R-NE)
- Sen. Gallego, Ruben [D-AZ] (D-AZ)
- Sen. Gillibrand, Kirsten E. [D-NY] (D-NY)
- Sen. Hassan, Margaret Wood [D-NH] (D-NH)
- Sen. Heinrich, Martin [D-NM] (D-NM)
- Sen. Hirono, Mazie K. [D-HI] (D-HI)
- Sen. Hoeven, John [R-ND] (R-ND)
- Sen. Hyde-Smith, Cindy [R-MS] (R-MS)
- Sen. Kelly, Mark [D-AZ] (D-AZ)
- Sen. Kennedy, John [R-LA] (R-LA)
- Sen. Kim, Andy [D-NJ] (D-NJ)
- Sen. Klobuchar, Amy [D-MN] (D-MN)
- Sen. Lankford, James [R-OK] (R-OK)
- Sen. McCormick, David [R-PA] (R-PA)
- Sen. Moran, Jerry [R-KS] (R-KS)
- Sen. Murkowski, Lisa [R-AK] (R-AK)
- Sen. Padilla, Alex [D-CA] (D-CA)
- Sen. Peters, Gary C. [D-MI] (D-MI)
- Sen. Reed, Jack [D-RI] (D-RI)
- Sen. Risch, James E. [R-ID] (R-ID)
- Sen. Rounds, Mike [R-SD] (R-SD)
- Sen. Scott, Rick [R-FL] (R-FL)
- Sen. Shaheen, Jeanne [D-NH] (D-NH)
- Sen. Slotkin, Elissa [D-MI] (D-MI)
- Sen. Smith, Tina [D-MN] (D-MN)
- Sen. Tillis, Thomas [R-NC] (R-NC)
- Sen. Van Hollen, Chris [D-MD] (D-MD)
- Sen. Warner, Mark R. [D-VA] (D-VA)
- Sen. Welch, Peter [D-VT] (D-VT)
- Sen. Wicker, Roger F. [R-MS] (R-MS)
Actions (2)
- Nov 20, 2025 Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S8278-8279) · senate
- Nov 20, 2025 Introduced in Senate
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Full text
IN THE SENATE OF THE UNITED STATES
November 20, 2025
Ms. Collins (for herself, Ms. Cortez Masto, Mrs. Capito, and Mr. Warner) introduced the following bill; which was read twice and referred to the Committee on Finance
A BILL
To amend title XVIII of the Social Security Act to provide for Medicare coverage of blood-based dementia screening tests.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Alzheimer’s Screening and Prevention Act” or the “ASAP Act”.
SEC. 2. MEDICARE COVERAGE OF ALZHEIMER’S DISEASE AND RELATED DEMENTIAS EARLY DETECTION SCREENING TESTS.
(a) Coverage.—Section 1861 of the Social Security Act (42 U.S.C. 1395x) is amended—
(1) in subsection (s)(2)—
(A) in subparagraph (JJ), by striking the semicolon at the end and inserting “; and”; and
(B) by adding at the end the following new subparagraph: “(KK) Alzheimer’s disease and related dementias early detection screening tests (as defined in subsection (nnn));” and
(2) by adding at the end the following new subsection: “(nnn) Alzheimer’s Disease and Related Dementias Early Detection Screening Tests.—The term ‘Alzheimer’s disease and related dementias early detection screening test’ means a test furnished to an individual for the detection of the pre-symptomatic and early stage of Alzheimer’s disease or related dementias on or after January 1, 2028, that—
“(1) is cleared under section 510(k), classified under section 513(f)(2), or approved under section 515 of the Federal Food, Drug, and Cosmetic Act; and
“(2) is—
“(A) a genomic sequencing blood or blood product test; or
“(B) such other equivalent test, including a single-analyte test, blood test analysis of cell-free nucleic acids, multiplex panel test, whole genome sequencing, protein expression, whole exome, whole transcriptome, and medical imaging (which are based on blood, blood products, tissue, urine or other biospecimen), as the Secretary determines appropriate in providing results comparable to those obtained with a test described in subparagraph (A).”.
(b) Payment.—Section 1833(h)(1)(A) of the Social Security Act (42 U.S.C. 1395l(h)(1)(A)) is amended by inserting “Alzheimer’s disease and related dementias early detection screening tests under section 1861(nnn) and” after “including”. <all>
Comments